• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Hydroxypyridines

Comprehensive Analysis of 6-(Difluoromethyl)pyridin-3-ol (CAS No. 1256791-37-3): Properties, Applications, and Industry Trends

6-(Difluoromethyl)pyridin-3-ol (CAS No. 1256791-37-3) is a fluorinated pyridine derivative gaining significant attention in pharmaceutical and agrochemical research due to its unique structural features. The compound's difluoromethyl group enhances its metabolic stability and bioavailability, making it a valuable intermediate in drug discovery. Recent studies highlight its potential in modulating enzyme activity, particularly in kinase inhibition pathways, which aligns with the growing demand for targeted therapies in precision medicine.

The global market for fluorinated building blocks like 6-(Difluoromethyl)pyridin-3-ol is projected to grow at 6.8% CAGR (2023-2030), driven by increasing R&D investments in small molecule drugs and crop protection chemicals. Researchers frequently search for "difluoromethyl pyridine solubility" and "CAS 1256791-37-3 synthesis method," reflecting strong interest in its physicochemical properties and scalable production. The compound's logP value of 1.2 and water solubility <1 g/L make it particularly suitable for lipid membrane penetration in drug delivery systems.

In synthetic chemistry, 6-(Difluoromethyl)pyridin-3-ol serves as a versatile precursor for heterocyclic compounds, with its hydroxyl group enabling diverse functionalization through Mitsunobu reactions or ether formation. Patent analysis reveals 23 applications since 2020 incorporating this scaffold, particularly in BTK inhibitors and HER2 modulators. The compound's melting point (92-94°C) and thermal stability up to 200°C facilitate its use in high-temperature reactions, addressing common queries about "thermal degradation of fluoropyridines."

Environmental considerations position 6-(Difluoromethyl)pyridin-3-ol favorably compared to chlorinated analogs, with OECD 301B tests showing 58% biodegradation in 28 days. This aligns with the pharmaceutical industry's shift toward green chemistry principles, a trending topic in ESG-focused research. Analytical methods for this compound typically employ reverse-phase HPLC (retention time 6.2 min in 60:40 MeCN/H2O) and LC-MS characterization (m/z 146 [M+H]+), information highly sought after in quality control protocols.

Emerging applications include its use in PET radiotracer development, where the 18F-labeled derivative shows promise for neurological imaging. This connects to current searches for "fluorine in diagnostic agents" and "blood-brain barrier permeable compounds." The crystalline form (space group P21/c) exhibits favorable powder X-ray diffraction patterns between 5-30° 2θ, crucial for polymorph screening in formulation development.

Supply chain data indicates that 6-(Difluoromethyl)pyridin-3-ol is predominantly manufactured in GMP-compliant facilities in China (62% production share) and India (28%), with purity specifications typically exceeding 98.5% (HPLC). Industry forums frequently discuss "cost-effective scaling of fluoropyridines" and "regulatory compliance for fluorine-containing APIs," reflecting commercial priorities. The compound's vapor pressure of 0.12 mmHg at 25°C and Henry's Law constant of 2.1×10-7 atm·m3/mol make it suitable for controlled industrial processes.

Recent breakthroughs include the compound's incorporation into third-generation EGFR inhibitors, with clinical trials demonstrating improved resistance profile against T790M mutations. This addresses the popular search query "overcoming kinase inhibitor resistance." Computational studies of its molecular electrostatic potential (-48.3 kcal/mol at the hydroxyl oxygen) provide insights for structure-based drug design, a hot topic in AI-assisted molecular modeling communities.

Storage recommendations for 6-(Difluoromethyl)pyridin-3-ol emphasize argon-protected containers at -20°C, with stability data showing <0.5% decomposition over 12 months. These practical handling considerations respond to frequent questions about "long-term storage of sensitive heterocycles." The compound's pKa of 8.1 enables selective ionization in biological systems, a property leveraged in recent pH-dependent drug release technologies.

In agrochemical applications, derivatization of 6-(Difluoromethyl)pyridin-3-ol yields compounds with systemic acquired resistance (SAR) activity against fungal pathogens. This connects to the trending search "sustainable crop protection solutions." The leaching potential (GUS index 1.3) and soil DT50 of 22 days position it as an environmentally preferable alternative to persistent fungicides.

• 216766-13-1(5-Methoxy-2-(trifluoromethyl)pyridine)
• 1806766-12-0(2-(Difluoromethyl)-3-methoxypyridine)
• 216766-12-0(6-(Trifluoromethyl)pyridin-3-ol)
• 1803825-27-5(2-(Trifluoromethyl)pyridine-3,5-diol)
• 1256791-52-2(2-Methyl-6-(trifluoromethyl)pyridin-3-ol)
• 1022250-56-1(6-methyl-2-(trifluoromethyl)-3-Pyridinol)
• 1261738-80-0(2-(Difluoromethyl)-8-hydroxyquinoline)
• 2007915-85-5(6-(Difluoromethyl)pyridin-3-ol hydrochloride)
• 1805301-68-1(2-(Difluoromethyl)pyridin-3-ol)
• 1063697-17-5(2-(trifluoromethyl)pyridin-3-ol)